知名学者引用


        除了所发表论文的被引用频次、期刊质量能够彰显学者的学术影响力以外,被知名学者引用也是一项学术评价的重要指标。
        当前同舟云学术认定的知名学者包括:诺贝尔奖、菲尔兹奖、图灵奖等奖项获得者,多个国家的院士,同舟云学术“2023全球学者学术影响力排行版”入榜的前10万学者等。

Kyoko,Hasebe Deakin University被知名学者引用:79人次(黄金会员以上可以申请导出本人论文被全部知名学者引用的数据)

1. 陆林 中国 山东第一医科大学 校长 中国科学院院士 Peripheral cytokine levels and response to antidepressant treatment in depression: a systematic revi..

2. Johann,Steiner 德国 Otto-von-Guericke University Glial cell deficits are a key feature of schizophrenia: implications for neuronal circuit maintenanc..

3. Hans-Gert,Bernstein 德国 Otto-von-Guericke University Glial cell deficits are a key feature of schizophrenia: implications for neuronal circuit maintenanc..

4. Young, Allan H. 英国 Kings College London Psilocybin for dementia prevention? The potential role of psilocybin to alter mechanisms associated ..

5. Aarsland, Dag 英国 Kings College London Psilocybin for dementia prevention? The potential role of psilocybin to alter mechanisms associated ..

6. Michael,Berk 澳大利亚 Deakin University Network-based drug repurposing for schizophrenia

7. Felipe,Dal-Pizzol 巴西 University of Extremo Sul Catarinense Prophylactic Minocycline for Delirium in Critically Ill Patients A Randomized Controlled Trial

8. Michael,Berk 澳大利亚 Deakin University Use of gene regulatory network analysis to repurpose drugs to treat bipolar disorder

9. Thomas Munk,Laursen 丹麦 University of Aarhus Association between doxycycline use and long-term functioning in patients with schizophrenia

10. Trine,Munk-Olsen 丹麦 University of Aarhus Association between doxycycline use and long-term functioning in patients with schizophrenia

11. Eduard,Vieta 西班牙 University of Barcelona Exploring Clinical Subgroups of Participants with Major Depressive Disorder that may Benefit from Ad..

12. Michael,Berk 澳大利亚 Deakin University Exploring Clinical Subgroups of Participants with Major Depressive Disorder that may Benefit from Ad..

13. Gin S,Malhi 澳大利亚 University of Sydney Exploring Clinical Subgroups of Participants with Major Depressive Disorder that may Benefit from Ad..

14. MICHAEL MAES 中国 电子科技大学 Exploring Clinical Subgroups of Participants with Major Depressive Disorder that may Benefit from Ad..

15. Shahin,Akhondzadeh 伊朗 University of Tehran Emerging drugs for the treatment of irritability associated with autism spectrum disorder

16. Irmgard,Tegeder 德国 Goethe University Frankfurt Repurposing of pexidartinib for microglia depletion and renewal

17. Michael,Berk 澳大利亚 Deakin University The Impact of N-acetylcysteine on Major Depression: Qualitative Observation and Mixed Methods Analys..

18. Gin S,Malhi 澳大利亚 University of Sydney The Impact of N-acetylcysteine on Major Depression: Qualitative Observation and Mixed Methods Analys..

19. Ashley I,Bush 澳大利亚 University of Melbourne The Impact of N-acetylcysteine on Major Depression: Qualitative Observation and Mixed Methods Analys..

20. Margaret J,Morris 澳大利亚 University of New South Wales Minocycline as Treatment for Psychiatric and Neurological Conditions: A Systematic Review and Meta-A..

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3